Table 2.
Summary of stent choices, immediate and follow-up outcomes after treatment, and complications.
| Patient No |
Stent diameter/ length, mm |
Immediate resultsa |
Immediate complications |
mRS at discharge |
Angiographic follow-up |
Clinic follow-up | ||
|---|---|---|---|---|---|---|---|---|
| Interval m, modality |
Follow-up resultsa |
Late neurological complications |
Interval m, mRS at latest follow-up |
|||||
| 1 | NF 3.5/15 |
I | 1 | 6 m, DSA |
I | None | 12 m, 1 | |
| 2 | NF 4.0/15 |
I | 0 | 8 m, MRA |
Stable | None | 12 m, 0 | |
| 3 | NF 4.0/20 |
I | TIA from transient MCA thrombosis at 18 h after treatment |
1 | 5 m, DSA |
II | None | 12 m, 0 |
| 4 | NF 3.5/15 |
II | 0 | 6 m, DSA |
II | None | 15 m, 0 | |
| 5 | NF 4.0/15 |
I | 0 | 6 m, DSA |
I | None | 15 m, 0 | |
| 6 | NF 3.5/20 |
I | NA | NA | NA | NA | NA | |
| 7 | EP 4.5/22 | II | 0 | 6 m, DSA |
III | None | 14 m, 0 | |
| 8 | NF 3.5/15 |
II | 0 | 6 m, MRA |
Stable | None | 10 m, 0 | |
| 9 | NF 4.0/20 |
I | 0 | 8 m, MRA |
Stable | None | 10 m, 0 | |
| 10 | NF 3.5/15 |
I | 0 | 3 m, MRA |
Stable | Minor stroke 0at 3 m |
6 m, 0 | |
|
a Embolization results were classified using the Raymond classification system: class I, complete occlusion; class II, residual neck; class III, residual sac. NF Neuroform stent; EP Enterprise stent; TIA transient ischemic attack; MCA middle cerebral artery; mRS modified ranking scale; DSA digital subtraction angiography; MRA magnetic resonance angiography of the head; m months; NA not applicable. | ||||||||